Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.40 |
| ▸ | ADH1C | P00326 | 1/20 | 0.40 |
| ▸ | ADH1A | P07327 | 1/20 | 0.40 |
| ▸ | ADH4 | P08319 | 1/20 | 0.40 |
| ▸ | ADH7 | P40394 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27196676 | 1.00 | ACE2 (0.48) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL4271879 | 1.00 | ACE2 (0.48) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL4274565 | 1.00 | ACE2 (0.48) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL27223056 | 1.00 | ACE2 (0.48) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL1873151 | 0.97 | OPRM1 (0.48) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL1645053 | 0.95 | ACE2 (0.45) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL27223874 | 0.95 | ACE2 (0.45) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL27470379 | 0.95 | ACE2 (0.45) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL27345411 | 0.92 | OPRM1 (0.44) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL27753327 | 0.92 | LMNA (0.55) | ACE2OPRM1LMNASPHK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118599729-B | Lactobacillus curvatus and application thereof in reducing goat milk product smell | 西北农林科技大学 | 2026-05-15 | — | — | CN | disclosed |
| US-20250197341-A1 | METHOD FOR INHIBITING CRYSTALLISATION | BIOSYNTHIS (FR) | 2025-06-19 | — | — | US | disclosed |
| CN-118599729-A | Lactobacillus curvatus and application thereof in reducing goat milk product smell | 西北农林科技大学 | 2024-09-06 | — | — | CN | disclosed |
| EP-4387582-A1 | METHOD FOR INHIBITING CRYSTALLISATION | Biosynthis (FR) | 2024-06-26 | — | — | EP | disclosed |
| CN-118079671-A | Preparation method and application of organic-ceramic composite loose nanofiltration membrane | 上海城市水资源开发利用国家工程中心有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-117940101-A | Method for inhibiting crystallization | 碧昂赛恩斯公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-113929245-B | Method and system for recycling high-chlorine produced water of gas field | 中国石油化工集团有限公司 | 2024-02-09 | — | — | CN | disclosed |
| WO-2023020979-A1 | METHOD FOR INHIBITING CRYSTALLISATION | BIOSYNTHIS (FR) | 2023-02-23 | — | — | WO | disclosed |
| CN-115677071-A | Equipment and process for efficiently and synergistically removing ammonia nitrogen and COD (chemical oxygen demand) in high-chlorine gas field water | 中石化石油工程技术服务有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-113929245-A | Method and system for recycling high-chlorine produced water of gas field | 中石化石油工程技术服务有限公司 | 2022-01-14 | — | — | CN | disclosed |
| WO-2012168395-A1 | NOVEL COLOR CONVERTER | BASF SE (DE) | 2012-12-13 | — | — | WO | disclosed |
| WO-2012023138-A2 | VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2012-02-23 | — | — | WO | disclosed |
| US-7678394-B2 | Analytical methods for identifying ginseng varieties | SHEN BAIHUA | 2010-03-16 | — | — | US | disclosed |
| WO-2009037283-A1 | METHOD FOR PRODUCING SUBSTRATES COATED WITH RYLENE TETRACARBOLIC ACID DIIMIDES | BASF SE (DE) | 2009-03-26 | — | — | WO | disclosed |
| US-20090078312-A1 | VERFAHREN ZUR HERSTELLUNG VON MIT RYLENTETRACARBONSAEUREDIIMIDEN BESCHICHTETEN SUBSTRATEN | BASF SE (DE) | 2009-03-26 | — | — | US | disclosed |
| US-20080175929-A1 | ANALYTICAL METHODS FOR IDENTIFYING GINSENG VARIETIES | SHEN BAIHUA | 2008-07-24 | — | — | US | disclosed |
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |
| US-4524230-A | Preparation of alkylaromatic compounds | UOP INC. (US) | 1985-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250197341-A1 | METHOD FOR INHIBITING CRYSTALLISATION | FASN, SCD5, NFKB2 | ACE2 449/4885OPRM1 4200/4885LMNA 149/4885 |
| US-20090078312-A1 | VERFAHREN ZUR HERSTELLUNG VON MIT RYLENTETRACARBONSAEUREDIIMIDEN BESCHICHTETEN SUBSTRATEN | AXIN2, NCSTN, NES | ACE2 601/4885OPRM1 4144/4885LMNA 2799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.